At A Glance
1
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and o...
2
Revenue is primarily driven by Product (34.2%) and Royalty (30.7%).
3
No significant events in the past 90 days.
—
Market Cap
—
Revenue
—
Net Income
Employees134
Fundamentals
How The Business Makes Money
Revenue by Segment
Product34.2%($352M)
Royalty30.7%($315M)
Big Bagor Belrapzo8.3%($85M)
Ryanodex8.1%($84M)
PEMFEXY6.6%($67M)
Vasopressin6.1%($63M)
Bendeka3.9%($40M)
Other Product1.3%($13M)
License0.9%($9M)
Activity
What Changed Recently
No significant events in the past 90 days.
Analyst View
Company Profile
CIK0000827871
ISINUS2697961082
CUSIP269796108
Phone201 326 5300
Address50 Tice Boulevard, Woodcliff Lake, NJ, 07677, US
SEC EDGAR